6533b821fe1ef96bd127b933

RESEARCH PRODUCT

MODIFICATION OF COAGULATION IMBALANCE DURING ANTITHROMBIN TREATMENT IN PREECLAMPTIC PATIENTS: OUR EXPERIENCE

Antonino GiarratanoD MangioneCalogero Riccardo BuscemiSalvatore Pirri

subject

medicine.medical_specialtyPediatricsbusiness.industryAntithrombinTEGCritical Care and Intensive Care MedicineSettore MED/40 - Ginecologia E OstetriciaPREECLAMPSIACoagulationPoster PresentationmedicineATIntensive care medicinebusinessmedicine.drug

description

Preeclamptic conditions are often associated with a natural inhibitor consumption. Many studies have evidenced validity of antithrombin (AT) treatment during preeclamptic conditions. The aim of the study is to restore a congruous coagulation imbalance with administration of AT under the guide of thromboelastographic monitoring (TEG).

yearjournalcountryeditionlanguage
2008-03-01
10.1186/cc6434http://hdl.handle.net/10447/61395